These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 10382944)
1. Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases. Huang XJ; Wiernik PH; Klein RS; Gallagher RE Med Oncol; 1999 Apr; 16(1):58-64. PubMed ID: 10382944 [TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3. Jiang XH; Wong BC; Yuen ST; Jiang SH; Cho CH; Lai KC; Lin MC; Kung HF; Lam SK Int J Cancer; 2001 Jan; 91(2):173-9. PubMed ID: 11146441 [TBL] [Abstract][Full Text] [Related]
3. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1. Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001 [TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells. McCafferty-Grad J; Bahlis NJ; Krett N; Aguilar TM; Reis I; Lee KP; Boise LH Mol Cancer Ther; 2003 Nov; 2(11):1155-64. PubMed ID: 14617789 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells. Wang R; Xia L; Gabrilove J; Waxman S; Jing Y Leukemia; 2013 Feb; 27(2):315-24. PubMed ID: 22751450 [TBL] [Abstract][Full Text] [Related]
6. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells. Wang Y; An R; Dong X; Pan S; Duan G; Sun X Urol Int; 2009; 82(2):214-21. PubMed ID: 19322013 [TBL] [Abstract][Full Text] [Related]
7. [Regulation of arsenic trioxide-inducing apoptosis]. Huang X Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):258-60. PubMed ID: 11601217 [TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL. Liu Q; Hilsenbeck S; Gazitt Y Blood; 2003 May; 101(10):4078-87. PubMed ID: 12531793 [TBL] [Abstract][Full Text] [Related]
9. MER1, a novel organic arsenic derivative, has potent PML-RARalpha-independent cytotoxic activity against leukemia cells. Golemovic M; Quintás-Cardama A; Manshouri T; Orsolic N; Duzkale H; Johansen M; Freireich EJ; Kantarjian H; Zingaro RA; Verstovsek S Invest New Drugs; 2010 Aug; 28(4):402-12. PubMed ID: 19468689 [TBL] [Abstract][Full Text] [Related]
10. TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt. Szegezdi E; Cahill S; Meyer M; O'Dwyer M; Samali A Br J Cancer; 2006 Feb; 94(3):398-406. PubMed ID: 16434995 [TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis. Sordet O; Rébé C; Leroy I; Bruey JM; Garrido C; Miguet C; Lizard G; Plenchette S; Corcos L; Solary E Blood; 2001 Jun; 97(12):3931-40. PubMed ID: 11389037 [TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide induces apoptosis in pancreatic cancer cells via changes in cell cycle, caspase activation, and GADD expression. Li X; Ding X; Adrian TE Pancreas; 2003 Aug; 27(2):174-9. PubMed ID: 12883267 [TBL] [Abstract][Full Text] [Related]
13. Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide. Liu L; Chen C; Gong W; Li Y; Edin ML; Zeldin DC; Wang DW J Pharmacol Exp Ther; 2011 Nov; 339(2):451-63. PubMed ID: 21846841 [TBL] [Abstract][Full Text] [Related]
14. Activation of PKCalpha downstream from caspases during apoptosis induced by 7-hydroxystaurosporine or the topoisomerase inhibitors, camptothecin and etoposide, in human myeloid leukemia HL60 cells. Shao RG; Cao CX; Pommier Y J Biol Chem; 1997 Dec; 272(50):31321-5. PubMed ID: 9395460 [TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide selectively induces early and extensive apoptosis via the APO2/caspase-8 pathway engaging the mitochondrial pathway in myeloma cells with mutant p53. Akay C; Gazitt Y Cell Cycle; 2003; 2(4):358-68. PubMed ID: 12851490 [TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells. Li X; Ding X; Adrian TE Cancer Invest; 2004; 22(3):389-400. PubMed ID: 15493360 [TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide-induced apoptosis in U937 cells involve generation of reactive oxygen species and inhibition of Akt. Choi YJ; Park JW; Suh SI; Mun KC; Bae JH; Song DK; Kim SP; Kwon TK Int J Oncol; 2002 Sep; 21(3):603-10. PubMed ID: 12168106 [TBL] [Abstract][Full Text] [Related]
18. Arsenic-induced apoptosis in malignant cells in vitro. Akao Y; Yamada H; Nakagawa Y Leuk Lymphoma; 2000 Mar; 37(1-2):53-63. PubMed ID: 10721769 [TBL] [Abstract][Full Text] [Related]
19. Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells. Yedjou C; Tchounwou P; Jenkins J; McMurray R J Hematol Oncol; 2010 Aug; 3():28. PubMed ID: 20796291 [TBL] [Abstract][Full Text] [Related]